Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,281 to 2,300 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma. | J Cancer | 2022 | 35399719 | PubTator, text mining | PubMed |
| SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA. | Front Cell Dev Biol | 2022 | 35399515 | PubTator, text mining | PubMed |
| The possible role of long non-coding RNAs in recurrent miscarriage. | Mol Biol Rep | 2022 | 35397764 | PubTator, text mining | PubMed |
| The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. | Mol Cancer | 2022 | 35395767 | PubTator, text mining | PubMed |
| m6A binding protein YTHDF2 in cancer. | Exp Hematol Oncol | 2022 | 35382893 | PubTator, text mining | PubMed |
| RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. | Semin Cancer Biol | 2022 | 35381329 | PubTator, text mining | PubMed |
| N6-methyladenosine modification contributes to arecoline-mediated oral submucosal fibrosis. | J Oral Pathol Med | 2022 | 35377493 | PubTator, text mining | PubMed |
| Identification of New m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients. | Front Cell Dev Biol | 2022 | 35372339 | PubTator, text mining | PubMed |
| Identification and Characterization of BmNPV m6A Sites and Their Possible Roles During Viral Infection. | Front Immunol | 2022 | 35371067 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Key m6A Modification Related Genes and Immune Infiltrates in Human Aortic Dissection. | Front Cardiovasc Med | 2022 | 35369349 | PubTator, text mining | PubMed |
| LncRNAs and Chromatin Modifications Pattern m6A Methylation at the Untranslated Regions of mRNAs. | Front Genet | 2022 | 35368653 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in the imbalanced inflammatory homeostasis of arsenic-induced skin lesions. | Environ Toxicol | 2022 | 35363433 | PubTator, text mining | PubMed |
| Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs. | Sci Rep | 2022 | 35361860 | PubTator, text mining | PubMed |
| Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4. | Signal Transduct Target Ther | 2022 | 35361747 | PubTator, text mining | PubMed |
Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3. | Front Microbiol | 2022 | 35359726 | PubTator, text mining | PubMed |
| Genetic Regulation of N6-Methyladenosine-RNA in Mammalian Gametogenesis and Embryonic Development. | Front Cell Dev Biol | 2022 | 35359444 | PubTator, text mining | PubMed |
| [METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2022 | 35356881 | PubTator, text mining | PubMed |
| N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis. | Bioengineered | 2022 | 35356854 | PubTator, text mining | PubMed |
| m6A Regulator-Mediated Methylation Modification Patterns and Characterisation of Tumour Microenvironment Infiltration in Non-Small Cell Lung Cancer. | J Inflamm Res | 2022 | 35356071 | PubTator, text mining | PubMed |
| METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism. | Cell Death Discov | 2022 | 35354789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=115